Welcome to Add-Aspirin

This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.

Add-Aspirin is a large randomised clinical trial, which is taking place in the UK and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.

Congratulations to our top 5 recruiting centres:

  1. University Hospitals Coventry & Warwickshire
  2. Worcestershire Royal Hospital
  3. Bristol Haematology & Oncology Centre
  4. Royal Marsden Hospitals
  5. Churchill Hospital, Oxford

*FOR GENERAL AND CLINICAL QUERIES, PLEASE CHECK OUR FAQs*

News


Add-Aspirin recruitment continues in India!


Add-Aspirin is now open at 9 centres in India:

  • Tata Memorial Hospital, Mumbai
  • Chennai Breast Centre
  • Jehangir Clinical Development Centre, Pune
  • Tata Medical Centre, Kolkata
  • Meditrina Institute of Medical Sciences, Nashik
  • Shatabdi Hospital, Nagpur
  • Vikram & Fortis Hospital, Bengaluru
  • Cancer Institute (WIA), Chennai
  • Regional Cancer Centre, Trivandrum

Read more

Quick Links

Register a participant

To RANDOMISE a participant please call +44 (0)20 7670 4777

Unblind a participant

Breast

We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer.

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here 

Top recruiters: Worcestershire Royal Hospital, Royal Marsden Hospitals, Churchill Hospital Oxford

PARTICIPANTS REGISTERED: 1930
PARTICIPANTS RANDOMISED: 1514

Colon/Rectum

We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here 

Top recruiters: Bristol Haematology & Oncology Centre, St James 's University Hospital, Darlington Memorial Hospital

PARTICIPANTS REGISTERED: 1105
PARTICIPANTS RANDOMISED: 855

Gastro

We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here

Top recruiters:
The Christie, St James's University Hospital, Manor Hospital, Leicester Royal Infirmary

PARTICIPANTS REGISTERED: 159
PARTICIPANTS RANDOMISED: 111

Prostate

We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer.

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here

Top recruiters: UCHW,  University Hospital of Wales, Bristol Haematology & Oncology Centre

PARTICIPANTS REGISTERED: 865
PARTICIPANTS RANDOMISED: 696

the trial is being jointly funded by